Wearable Monitor in Patients With Syncope
Watch-VD
Feasibility of Blood Pressure Measurement With a Wearable (Watch-type) Monitor in Patients With Syncope
1 other identifier
interventional
81
1 country
1
Brief Summary
The main purpose of this study is to assess the reliability of a new patient's self-administered wearable watch-type BP monitor in detecting episodes of hypotensive (pre)syncope. Secondary aim regards the estimation of feasibility of this tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 11, 2023
CompletedFirst Posted
Study publicly available on registry
March 23, 2023
CompletedFebruary 20, 2024
February 1, 2024
8 months
March 11, 2023
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BP during event during tilt testing
Difference between baseline (rest) BP and BP at the presyncopal event ("Delta BP slope") during tilt testing with HeartGuide and with control
2 hours
Secondary Outcomes (1)
Compliance
2 hours
Study Arms (2)
Cuffless BP monitoring
EXPERIMENTALInvestigational device Omron HeartGuide® 6410T
Beat-to-beat BP monitoring
ACTIVE COMPARATORContinuous finger BP monitoring (Finometer®, Finapres Medical Systems, Enchede, The Netherlands, and Task Force® monitor, CNSystem, Graz, Austria), based on the photoplethysmographic volume clamp method
Interventions
Wearable (watch-type) monitor: HeartGuide 6410T (Omron Healthcare, Kyoto, Japan)
Eligibility Criteria
You may qualify if:
- Consecutive patients,
- \>18 years of age, referred for tilt testing because affected by suspected reflex syncope
You may not qualify if:
- Arrhythmias or the inability of HeartGuide to measure BP supine at rest.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituto Auxologico Italiano
Milan, MI, 16149, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2023
First Posted
March 23, 2023
Study Start
May 25, 2021
Primary Completion
January 31, 2022
Study Completion
June 30, 2022
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- Aafter publication of the princiapl study
- Access Criteria
- m.brignole@auxologico.it
Data will be available upon reasonable request to the principal investigator